Bionano Genomics, Inc.

NASDAQ:BNGO

3.99 (USD) • At close April 30, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

202420232022202120202019201820172016
Operating Activities:
Net Income -112.017-232.493-132.596-72.435-41.106-29.815-18.496-23.365-18.849
Depreciation & Amortization 14.22613.9129.843.371.481.1281.3211.5041.115
Deferred Income Tax 001.76-5.7771.9351.9-2.4590.479-3.006
Stock Based Compensation 9.73615.17822.4179.7191.5541.3461.3090.3830.131
Change In Working Capital 0-14.769-28.588-7.652-3.44-4.972-2.3690.085-2.961
Accounts Receivables 4.139-2.296-2.9-0.4932.087-2.374-0.9-1.768-0.856
Inventory 7.231-4.15-23.676-15.928-4.201-3.641-0.419-0.336-0.726
Accounts Payables -3.42-1.9951.9496.781-1.8091.362-0.9541.541-0.609
Other Working Capital 0-6.328-3.9611.9880.483-0.319-0.0950.647-0.77
Other Non Cash Items 19.13392.9912.3510.8481.2640.8830.750.0970.074
Operating Cash Flow -68.922-125.181-124.816-71.927-38.314-29.53-19.944-20.818-23.496
Investing Activities:
Investments In Property Plant And Equipment -0.103-1.691-3.302-1.460-0.061-0.332-1.018-1.35
Acquisitions Net 00.096-31.344-49.086-2.450000
Purchases Of Investments -233.021-111.264-84.195-313.39200000
Sales Maturities Of Investments 306.963137.017200.88886.48300000
Other Investing Activites 000.72-0.60700000
Investing Cash Flow 73.83924.15882.767-278.062-2.45-0.061-0.332-1.018-1.35
Financing Activities:
Debt Repayment -48.058-0.047-0.036-15.005-4.7239.8216.38301.886
Common Stock Issued 44.43357.69723.128342.71139.93419.55619.3917.60823.545
Common Stock Repurchased 000000000
Dividends Paid 000000000
Other Financing Activities -10.0656.165-0.0858.40526.6911.0030.00317.60823.545
Financing Cash Flow -13.685113.81523.007336.11161.90230.37935.77617.60825.431
Other Information:
Effect Of Forex Changes On Cash -0.0070.065-0.038000000
Net Change In Cash -8.77512.857-19.08-13.87821.1370.78915.501-4.2280.585
Cash At End Of Period 9.57318.3485.49124.57138.44917.31116.5231.0225.25